Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 2

Results: 16

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 83, doi. 10.1111/jvh.12313

By:

Hou, J. L.;
Gao, Z. L.;
Xie, Q.;
Zhang, J. M.;
Sheng, J. F.;
Cheng, J.;
Chen, C. W.;
Mao, Q.;
Zhao, W.;
Ren, H.;
Tan, D. M.;
Niu, J. Q.;
Chen, S. J.;
Pan, C.;
Tang, H.;
Wang, H.;
Mao, Y. M.;
Jia, J. D.;
Ning, Q.;
Xu, M.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. i, doi. 10.1111/jvh.12319
Publication type:: Article

Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 101, doi. 10.1111/jvh.12260

By:

Raouf, H. E.;
Yassin, A. S.;
Megahed, S. A.;
Ashour, M. S.;
Mansour, T. M.

Publication type:

Article

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 135, doi. 10.1111/jvh.12262

By:

Younossi, Z. M.;
Otgonsuren, M.;
Henry, L.;
Arsalla, Z.;
Stepnaova, M.;
Mishra, A.;
Venkatesan, C.;
Hunt, S.

Publication type:

Article

PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 199, doi. 10.1111/jvh.12265

By:

Lv, J.;
Zhu, P.;
Yang, Z.;
Li, M.;
Zhang, X.;
Cheng, J.;
Chen, X.;
Lu, F.

Publication type:

Article

Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 144, doi. 10.1111/jvh.12266

By:

Boštjančič, E.;
Bandelj, E.;
Luzar, B.;
Poljak, M.;
Glavač, D.

Publication type:

Article

rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 182, doi. 10.1111/jvh.12280

By:

Chowdhury, S. J.;
Karra, V. K.;
Gumma, P. K.;
Bharali, R.;
Kar, P.

Publication type:

Article

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 118, doi. 10.1111/jvh.12283

By:

Papatheodoridis, G. V.;
Manolakopoulos, S.;
Touloumi, G.;
Nikolopoulou, G.;
Raptopoulou‐Gigi, M.;
Gogos, C.;
Vafiadis‐Zouboulis, I.;
Karamanolis, D.;
Chouta, A.;
Ilias, A.;
Drakoulis, C.;
Mimidis, K.;
Ketikoglou, I.;
Manesis, E.;
Mela, M.;
Hatzis, G.;
Dalekos, G. N.

Publication type:

Article

Serum micro RNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 126, doi. 10.1111/jvh.12284

By:

Wang, J.‐Y;
Mao, R.‐C;
Zhang, Y.‐M;
Zhang, Y.‐J;
Liu, H.‐Y;
Qin, Y.‐L;
Lu, M.‐J;
Zhang, J.‐M

Publication type:

Article

Treating Immune-tolerant Hepatitis B.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 75, doi. 10.1111/jvh.12370

By:

Tseng, T.‐C.;
Kao, J.‐H.

Publication type:

Article

Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 92, doi. 10.1111/jvh.12258

By:

Yasui, S.;
Fujiwara, K.;
Nakamura, M.;
Miyamura, T.;
Yonemitsu, Y.;
Mikata, R.;
Arai, M.;
Kanda, T.;
Imazeki, F.;
Oda, S.;
Yokosuka, O.

Publication type:

Article

Predictive value of serum actin-free Gc-globulin for complications and outcome in acute liver failure.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 190, doi. 10.1111/jvh.12259

By:

Bagchi, A.;
Kumar, S.;
Ray, P. C.;
Das, B. C.;
Gumma, P. K.;
Kar, P.

Publication type:

Article

Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 156, doi. 10.1111/jvh.12271

By:

Kosaka, K.;
Imamura, M.;
Hayes, C. N.;
Abe, H.;
Hiraga, N.;
Yoshimi, S.;
Murakami, E.;
Kawaoka, T.;
Tsuge, M.;
Aikata, H.;
Miki, D.;
Ochi, H.;
Matsui, H.;
Kanai, A.;
Inaba, T.;
Chayama, K.

Publication type:

Article

Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphism.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 164, doi. 10.1111/jvh.12275

By:

Akamatsu, S.;
Hayes, C. N.;
Tsuge, M.;
Murakami, E.;
Hiraga, N.;
Abe, H.;
Miki, D.;
Imamura, M.;
Ochi, H.;
Chayama, K.

Publication type:

Article

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 173, doi. 10.1111/jvh.12278

By:

Cortesi, P. A.;
Ciaccio, A.;
Rota, M.;
Lim, J. K.;
De Salvia, S.;
Okolicsanyi, S.;
Vinci, M.;
Belli, L. S.;
Mantovani, L. G.;
Strazzabosco, M.

Publication type:

Article

Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 predicts prognosis of acute-on-chronic hepatitis B liver failure.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 110, doi. 10.1111/jvh.12277

By:

Gao, S.;
Ji, X.‐F.;
Li, F.;
Sun, F.‐K.;
Zhao, J.;
Fan, Y.‐C.;
Wang, K.

Publication type:

Article